S-Ofloxacin, the optically active form of ofloxacin, was twice as active as the S,R mixture of ofloxacin against members of the family Enterobacteriaceae, Pseudomonas aeruginosa, and gram-positive species. Of the Enterobacteriaceae, 90% were inhibited by .1 ,ug/ml and 90% of Staphylococcus aureus and Streptococcus pyogenes isolates were inhibited by 0.5 ,ig/ml. Bacteroides fragilis was inhibited by 4 jig/ml. Organisms resistant to ofloxacin were resistant to S-ofloxacin. Like ofloxacin activity, the activity of S-ofloxacin was reduced by Mg2' and by acid pH. Spontaneous mutational resistance to S-ofloxacin was similar to that to ofloxacin.
There has been continued interest in improving the antibacterial activity of the new quinolone antimicrobial agents. Ofloxacin exists as two optically active forms because of the asymmetric center at position C-3 of the oxazine ring that links the N-1 and C-8 positions. Preliminary studies have shown that the S isomer of ofloxacin was more active than the mixture (3) . Similar results have been shown for the S isomer of S-25930 (2, 9) . We wished to determine the activity of the S isomer compared with that of ofloxacin against clinical isolates, including strains collected from patients treated with ofloxacin or ciprofloxacin.
S-Ofloxacin and ofloxacin were gifts from Ortho Pharmaceutical Corp., Raritan, N.J. Organisms were isolates from patients seen at The Columbia-Presbyterian Medical Center in New York City and included isolates from patients treated in clinical evaluations of ofloxacin and ciprofloxacin. MICs were determined by the National Committee for Clinical Laboratory Standards procedures (7) with Mueller-Hinton agar (BBL Microbiology Systems, Cockeysville, Md.). GC agar was supplemented with lysed sheep blood and IsoVitaleX for Neisseria, Hlaemnophilums, and Br-anhamella species. Brucella agar supplemented with 5% sheep blood, hemin, and vitamin K was used for anaerobic species. Incubation was for 48 h at 35°C in GasPak jars (BBL). Bactericidal activity was determined as outlined by National Committee for Clinical Laboratory Standards (6) . The effect of growth conditions was as previously described (4) . The selection of resistant isolates and spontaneous mutants was as previously described (1) . Porin mutants used were a gift of H. Nakaido.
The overall activity of S-ofloxacin compared with that of ofloxacin is given in Table 1 . The MIC of S-ofloxacin at which 90% of the members of the family Eniterobaicterilaceie were inhibited with 1 pg/ml. This was twofold less than the MIC of ofloxacin. In virtually every instance, the MIC of S-ofloxacin was, on repeat testing, 1 The activities of S-ofloxacin were similar in MuellerHinton, brain heart infusion, and nutrient agars. The addition of 50% human serum did not alter the activity. The addition of Mg2- (Table 2 ) caused an increase in MICs and MBCs, but the drug remained twofold more active than ofloxacin. The addition of calcium had no effect. Activity of S-ofloxacin was also decreased for E. coli, Klebsiellai pnleumlonti(ae, Serratia inarcescenis, and P. (ieleruginiosa when assays were performed with urine (pH 5.5) as medium, and there was a four-to eightfold increase in MICs and MBCs at pH 5.5 over those at pH 7.4, but the activity of S-ofloxacin was always superior to that of ofloxacin (data not shown).
The frequency of development of spontaneous resistance to S-ofloxacin to fourfold the MIC was 10' to 10'1( for two isolates each of E. coli, K. plleiumnoni(le, S. m(arcescens, and P. aieruiginiosai. The MICs of S-ofloxacin were increased for an E. coli isolate selected for resistance to ofloxacin by repeated subculture and for a P. aerugin(osa strain isolated from a patient with cystic fibrosis who had been treated with ofloxacin (Table 3) . As before, MICs of S-ofloxacin were twofold lower than those of ofloxacin. The S-ofloxacin MIC for E. coli mutants which were OmpF-was 0.06 p.g/ml, compared with an ofloxacin MIC of 0.12 p.g/ml. The MICs of both drugs were twofold lower for the parent E. coli OmpF+ OmpCt strains. These studies confirm and extend earlier observations about the activity of the isomer of ofloxacin (3, 8) . The difference in the activity has been shown to be related to the DNA gyrase activity (5). The S isomer of compound S-ANTIMICROB. AGENTS CHEMOTHER. 
